Phenotypic Variation in Hyperandrogenic Women Influences the Findings of Abnormal Metabolic and Cardiovascular Risk Parameters
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
In hyperandrogenic women, several phenotypes may be observed. This includes women with classic polycystic ovary syndrome (C-PCOS), those with ovulatory (OV) PCOS, and women with idiopathic hyperandrogenism (IHA), which occurs in women with normal ovaries. Where other causes have been excluded, we categorized 290 hyperandrogenic women who were seen consecutively for this complaint between 1993 and 2004 into these three subgroups. The aim was to compare the prevalence of obesity, insulin resistance, and dyslipidemia as well as increases in C-reactive protein and homocysteine in these different phenotypes with age-matched ovulatory controls of normal weight (n = 85) and others matched for body mass index (BMI) with women with C-PCOS (n = 42). Although BMI affected fasting serum insulin and the Quantitative Insulin-Sensitivity Check Index, these markers of insulin resistance were greatest in C-PCOS (n = 204), followed by OV-PCOS (n = 50) and then IHA (n = 33). Androgen levels were similar in OV-PCOS and IHA but were higher in C-PCOS, whereas gonadotropins were similar in all groups. Lipid abnormalities were highest in C-PCOS and OV-PCOS and were normal in IHA. C-reactive protein was elevated in C-PCOS and OV-PCOS but not IHA. Homocysteine was elevated only in C-PCOS. Overall, the prevalence of obesity (BMI > 30) was 29% in C-PCOS, 8% in OV-PCOS, and 15% in IHA and insulin resistance (Quantitative Insulin-Sensitivity Check Index < 0.33) was 68% in C-PCOS, 36% in OV-PCOS, and 26% in IHA. The prevalence of having at least one elevated cardiovascular risk marker was 45% in C-PCOS 38% in OV-PCOS and was not increased on IHA (6%). These results suggest that among hyperandrogenic women the prevalence of abnormal metabolic and cardiovascular risk parameters is greatest in C-PCOS, followed by OV-PCOS and then women with IHA. Moreover, in that in OV-PCOS and IHA, ages and weights were similar yet the prevalence of metabolic and cardiovascular risk was greater in OV-PCOS, the finding of polycystic ovaries may be a significant modifying factor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931 · cited 8×
“The following criteria were considered as being abnormal: obesity, BMI 30 or more; insulin resistance, QUICKI 0.330 or less (16); dyslipidemia, total cholesterol, 200 mg/dl or more and/or HDL-cholesterol, 40 mg/dl or less, and/or LDL-cholesterol, 130 mg/dl or more, and/or triglycerides, 150 mg/dl or more.”
MethodInfluentialMen at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Ultrasound assessment of the polycystic ovary: international consensus definitions
Balen, A. H., Laven, J. S. E., Tan, S.-L., & Dewailly, D. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg044 · Cited by 1,015
Polycystic ovary syndrome and cardiovascular disease: a premature association?
Legro, R. S. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0004 · Cited by 466 · cited 1×
“It is interesting to note that, in our patients with C-PCOS, the HDL-cholesterol levels were higher and the triglyceride levels were lower than those reported in other studies of women with PCOS ( 19 ).”
ResultDepartment of Obstetrics and Gynecology
(2015) · Juntendo Medical Journal · doi:10.14789/jmj.61.322 · Cited by 365
Carmina, E., & Lobo, R. A. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.01.041 · Cited by 294
Self-citationCarmina, E. (2003) · Human Reproduction · doi:10.1093/humrep/deg440 · Cited by 197
Self-citation
Research works printed but not linked: 1
- Zawdaki, 1992, Diagnostic criteria for polycystic ovary syndrome: toward a rationale approach, In: Dunaif A, Givens JR, Haseltine F, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications;, 377
Cited by
Items 201–300 of 310
Obesity in Polycystic Ovary Syndrome: Insulin Sensitizing Therapy
Hoeger, K. M. (2012) · Current Obesity Reports · doi:10.1007/s13679-012-0030-y · Cited by 6
Gomes, V. A., Vieira, C. S., Jacob‐Ferreira, A. L., Belo, V. D. A., Soares, G. M., França, J. B., Ferriani, R. A., & Tanus-Santos, J. E. (2012) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2012.00895.x · Cited by 6
Polycystic ovary syndrome: prognosis and risk of comorbidity
Hardy, T., Sousa, S. D., & Norman, R. J. (2013) · doi:10.2217/ebo.12.214 · Cited by 6
Çintesun, F. N. İ., Can, Ü., Çintesun, E., Altunkeser, A., Kaya, A., & Günenç, O. (2021) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.galenos.2021.51436 · Cited by 6
Androgens and Hirsutism in a Large Cohort of Portuguese Women
Pinto, J., Cera, N., Camerino, C., Beires, J., & Pignatelli, D. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14030673 · Cited by 6
Canpolat, A. G., Demir, Ö., Sert, M. S., Yarsan, B., Tekfidan, Z., Yaman, Ş. N., Oğuz, E., Gazal, E., Şimşek, H. H., Ensarı, T. A., et al. (2021) · Journal of Ankara University Faculty of Medicine · doi:10.4274/atfm.galenos.2021.52244 · Cited by 6
The Evaluation and Treatment of Hirsute Women
Ünlühızarcı, K., Şahin, Y., & Keleştimur, F. (2005) · Women s Health · doi:10.2217/17455057.1.3.429 · Cited by 6
Heterogenous forms of dyslipidemiain women with polycystic ovary syndrome
Gulotta, G., Agrusa, A., Cusumano, G., Pepe, I., Rinella, M., Fertitta, E., Gulotta, P., Giammanco, A., Scozzari, F., Vassallo, L., et al. (2008) · Nova Science Publishers (Nova Science Publishers, Inc.) · Cited by 6
Phenotypic Variation of Polycystic Ovary Syndrome
Pyun, G. W., Choi, Y. J., Lee, H., Oh, J. Y., Hong, Y. S., Sung, Y., & Chung, H. W. (2007) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2007.22.5.326 · Cited by 5
Insulin resistance in polycystic ovary syndrome: maker or marker?
Bozdağ, G., & Yıldız, B. O. (2010) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.09.73 · Cited by 5
Alebić, M. Š., Stojanović, N., Baldani, D. P., & Duvnjak, L. S. (2016) · Endocrine · doi:10.1007/s12020-016-1062-y · Cited by 5
Dogan, M. I., Taşçı, İ., Bulucu, F., Aydoğdu, A., Acar, R., Ceyhan, T., Koç, B., Demir, O., Gezer, M., & Sağlam, K. (2012) · Angiology · doi:10.1177/0003319711436248 · Cited by 5
Hu, Y., Chen, B., Pan, Y., Xing, K., Xiao, Z., Sheng, B., Li, J., Dong, H., & Lv, F. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1374718 · Cited by 5
Autonomic dysfunction in polycystic ovary syndrome
Adams, Z. H., Simpson, L. L., Hart, E. C., & Lord, R. N. (2025) · Autonomic Neuroscience · doi:10.1016/j.autneu.2025.103357 · Cited by 4
Ovulation Induction in Anovulatory Patients with Polycystic Ovary Syndrome
Falbo, A. I., Palomba, S., Russo, T., Cello, A. D., & Zullo, F. (2010) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-1092 · Cited by 4
Carmina, E., & Longo, R. A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15135165 · Cited by 4
Self-citationSteroids and One-Carbon Metabolism: Clinical Implications in Endocrine Disorders
Scheyer, N., Guéant‐Rodriguez, R., Agopiantz, M., & Leininger‐Muller, B. (2025) · Neuroendocrinology · doi:10.1159/000547151 · Cited by 4
Cardiometabolic risk in women with polycystic ovary syndrome: a comprehensive review
Cagnacci, A., ANTONELLI, G. A., VATTERONI, G., & Xholli, A. (2025) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.25.05732-x · Cited by 4
Burwitz, B. J., Yusova, S., Robino, J. J., Takahashi, D. L., Luo, A., Slayden, O. D., Bishop, C. V., Hennebold, J. D., Roberts, C. T., & Varlamov, O. (2023) · American Journal of Reproductive Immunology · doi:10.1111/aji.13773 · Cited by 4
Fat Distribution and Adipose Products in Polycystic Ovary Syndrome
Carmina, E. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_2 · Cited by 4
Self-citationThe effectiveness of exercise in the treatment of polycystic ovary syndrome
Kite, C. (2020) · Aston Publications Explorer (Aston University) · doi:10.48780/publications.aston.ac.uk.00042574 · Cited by 4
Wang, D., Cao, J.-X., Jiang, W.-J., Hou, J.-W., Yan, M.-H., Sun, Z., & Song, J. (2023) · Medicine · doi:10.1097/md.0000000000033049 · Cited by 4
Caring for women with polycystic ovary syndrome
Pereira, K. C., & Kreider, K. E. (2016) · The Nurse Practitioner · doi:10.1097/01.npr.0000480586.24537.64 · Cited by 3
Hyperandrogenism in Women: Polycystic Ovary Syndrome
Sung, Y. (2012) · Hanyang Medical Reviews · doi:10.7599/hmr.2012.32.4.197 · Cited by 3
When Periods Stop: Long-Term Consequences of PCOS
Carmina, E., Guastella, E., & Rizzo, M. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_23 · Cited by 3
Self-citationMetabolic and lipoprotein aspects of polycystic ovarian syndrome
Pazderska, A., & Gibney, J. (2015) · Clinical Lipidology · doi:10.2217/clp.15.12 · Cited by 3
[The polycystic ovary syndrome. The point of view of the internist].
Rodríguez-Flores, M. (2011) · PubMed · Cited by 3
Zheng, Y., Xu, Y., Ma, H., Liang, C., & Yang, T. (2021) · Research Square · doi:10.21203/rs.3.rs-97809/v3 · Cited by 3
Hara, S., Takahashi, T., Igarashi, H., Amita, M., Matsuo, K., Hasegawa, A., & Kurachi, H. (2014) · Journal of Mammalian Ova Research · doi:10.1274/jmor.31.2 · Cited by 3
Metabolic syndrome in children unravelled
Thankamony, A., Williams, R. M., & Dunger, D. B. (2011) · Paediatrics and Child Health · doi:10.1016/j.paed.2011.03.010 · Cited by 3
Exploring the activity of the enzyme 11β-hydroxylase in the polycystic ovary syndrome
de Medeiros, S. F., Angelo, L. C. A., de Medeiros, M. A. S., Barbosa, B. B., & Yamamoto, M. M. W. (2020) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2019-0048 · Cited by 2
Boyle, J. A. (2011) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 2
Wheeler, C. J., Keye, W. R., & Peterson, C. M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1436-1_11 · Cited by 2
Síndrome de ovario poliquístico y riesgo cardiovascular
Sesmilo, G., & González‐Sastre, F. (2007) · Medicina Clínica · doi:10.1157/13109704 · Cited by 2
Movahedinejad, M., Ziaei, S., Kazemnezhad, A., & Kamali, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-864589/v1 · Cited by 2
Polycystic Ovary Syndrome and Cardiovascular Disease: An Enigmatic Relationship
Mukherjee, S. (2017) · Global Journal of Reproductive Medicine · doi:10.19080/gjorm.2017.01.555571 · Cited by 2
Intergenerational Implications of PCOS
Willging, M. M., Abbott, D. H., & Dumesic, D. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_27 · Cited by 2
Chronic Treatment of Polycystic Ovary Syndrome
Nader, S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_9 · Cited by 2
Cardiovascular Disease and Inflammation
Orio, F., Diamanti‐Kandarakis, E., & Palomba, S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_13 · Cited by 2
Ünlühızarcı, K., & Keleştimur, F. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_6 · Cited by 2
Mani, H. (2014) · Figshare · Cited by 2
Epidemiology and Diagnostic Criteria of Polycystic Ovary Syndrome
Lee, H., & Sung, Y. (2015) · Journal of Korean Diabetes · doi:10.4093/jkd.2015.16.3.189 · Cited by 1
IVF efficiency in different phenotypes of polycystic ovary syndrome
Nikolayenkov, I. P., Kazymova, O. E., Sudakov, D. S., & Dymarskaya, Y. R. (2021) · Journal of obstetrics and women s diseases · doi:10.17816/jowd61933 · Cited by 1
Polycystic Ovary Syndrome, Obesity and Insulin Resistance
Cassar, S. (2014) · Victoria University Research Repository (Victoria University) · Cited by 1
Aye, M. M. (2013) · Repository@Hull (Worktribe) (University of Hull) · Cited by 1
Definition and Epidemiology of the Polycystic Ovary Syndrome
Azziz, R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_13 · Cited by 1
Marcadores precoces de doença cardiovascular em mulheres com síndrome dos ovários policísticos
Soares, G. M. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2008.tde-26092013-164044 · Cited by 1
Lifestyle Intervention in Polycystic Ovarian Syndrome
Janssen, O. E., Tan, S., & Hahn, S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_28 · Cited by 1
Polycystic Ovary Syndrome and the Metabolic Syndrome
Janssen, O. E., Tan, S., Dietz, T., & Hahn, S. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-37 · Cited by 1
Metabolic complications in a large cohort of Portuguese women with hirsutism-related disorders
Pinto, J., Cera, N., & Pignatelli, D. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02744-9 · Cited by 1
Polycystic ovary syndrome and cardiovascular risk
Popova, P., Gorelova, I. V., & Grineva, E. N. (2019) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2018-24-6-654-665 · Cited by 1
A case–control study on reduced HDL2b in patients with polycystic ovarian syndrome
Hu, W., Chen, L., Mao, S., & Qiao, J. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1182151 · Cited by 1
The Polycystic Ovary Syndrome Status - A Risk Factor for Future Cardiovascular Disease
Ilie, I. R. P., Ilie, R., MOCAN, L. C., Georgescu, C. E., Duncea, I., Mocan, T., Ghibu, S., & Iancu, C. (2012) · InTech eBooks · doi:10.5772/32072 · Cited by 1
Zheng, Y., Xu, Y., Ma, H., Liang, C., & Yang, T. (2020) · Research Square · doi:10.21203/rs.3.rs-97809/v2 · Cited by 1
Kalı, Z., & Çağiran, F. T. (2023) · Eurasian Clinical and Analytical Medicine · doi:10.4328/ecam.10054 · Cited by 1
MADENLİ, A. A., & Özer, G. (2023) · Journal of Controversies in Obstetrics & Gynecology and Pediatrics · doi:10.51271/jcogp-0020 · Cited by 1
Risco de Farmingham e evento cardiovascular em mulheres com síndrome dos ovários policísticos
Santos, A. G. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Das polyzystische Ovarsyndrom – Metabolische Konsequenzen
Tan, S., Hahn, S., & Janssen, O. E. (2008) · Gyn�kologisch-geburtshilfliche Rundschau · doi:10.1159/000111466 · Cited by 1
Diagnostic and predictive biomarkers of polycystic ovary syndrome in Nigeria: a mini-review
Suleiman, H. A., & Ayodeji, A. S. (2026) · Middle East Fertility Society Journal · doi:10.1186/s43043-026-00315-3 · Cited by 1
Diagnosis and Multidisciplinary Management of Polyendocrine Metabolic Ovarian Syndrome
Valdez‐Sinon, A. N., Hosseinzadeh, P., & Moragianni, V. A. (2026) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2026.08.004 · Cited by 1
Freire, G. I. D. M., Chein, M. B. D. C., Ribeiro, Á. S. S., Mascarenhas, T. S., Costa, J. P. L., de Sousa, R. M. L., & Brito, L. M. O. (2012) · Revista de Pesquisa em Saúde · Cited by 1
SÍNDROME DO OVARÍO POLICÍSTICO (SOP) E SUA ASSOCIAÇÃO COM COMPLICAÇÕES NA GRAVIDEZ
de Melo, A. B. O., do Nascimento, M. E. B., da Rosa, V. H. J., Ribeiro, R. D. M., Reis, G. F., Lopes, S. N. O. D. S., de Miranda, V. C. A. L., Bastos, M. C. S., Santos, G. A., RIBEIRO, T. M. D. C., et al. (2024) · Brazilian Journal of Implantology and Health Sciences · doi:10.36557/2674-8169.2024v6n4p2055-2064 · Cited by 1
Huang, X., Chen, Z., Zhang, L., & Li, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1797826
Variations in the Expression of the Polycystic Ovary Syndrome Phenotype
Carmina, E. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_8
Self-citationBass, I. R., Nosova, E. V., & Dunaif, A. E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00085-8
Halder, D., Varshini, P., V, Mitra, T., Kumar, A. H. S. A., Agrawal, P., Das, M., Kumar, A. H. S. A., Kumari, R. S., Sundari, S. N. M., & Janardhanan, R. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1868855
Antoniou-Tsigkos, A., Καρράς, Γ., Papagianni, M., CHRISTOPOULOS, P. F., Vlahos, N. F., & Mastorakos, G. M. (2025) · Endocrine · doi:10.1007/s12020-025-04527-x
Hypertension and Cardiovascular and Lipoprotein Abnormalities in the Polycystic Ovary Snydrome
Orio, F., & Palomba, S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_29
Pedroso, D. C. C. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2018.tde-19072018-102713
Characterisation of microparticles and nitro-oxidative stress in cardiometabolic disease
Willis, G. R. (2015) · ORCA Online Research @Cardiff (Cardiff University)
Dietary management of Polycystic ovary syndrome.
Moran, L. (2007) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Rodríguez-Flores, M. (2011)
Santana, L. F. (2007) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2007.tde-26092013-155217
Loucks, T. L. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Zheng, Y., Ma, H., Xu, Y., Liang, C., & Yang, T. (2020) · Research Square · doi:10.21203/rs.3.rs-97809/v1
Ghatnatti, V., Patil, S., Kour, H., Bhuyan, A. K., Choudhary, B. K., Saikia, U. K., & Sharma, D. (2021) · BLDE University Journal of Health Sciences · doi:10.4103/bjhs.bjhs_124_20
Roshan, V. D., & Zadeh, Z. A. T. (2025) · Science & Sports · doi:10.1016/j.scispo.2025.07.006
GÜRBÜZ, T., & Tosun, Ş. A. (2021) · Journal of Experimental and Clinical Medicine · doi:10.52142/omujecm.38.4.15
Hussein, R. A., Ali, I. N., & Sayer, S. A. (2023) · Academia Open · doi:10.21070/acopen.8.2023.7830
Clinical Manifestation of Polycysticv Ovary Syndrome
Ahn, Y. (2007) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2007.22.5.323
Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., Witchel, S. F., Azziz, R., Carmina, E., Dewailly, D., Diamanti‐Kandarakis, E., & Escobar-Morreale, H. F. (2006)
Self-citationYarmolinskaya, M. I., Glavnova, O. B., Osinovskaya, N. S., Ворохобина, Н. В., Великанова, Л. И., & Musevich, K. D. (2026) · Bulletin of Reproductive Health · doi:10.14341/brh12790
Salwa Asif, K. C., Chintharala, K., AlSaafeen, A., Adusumilli, M., Lingarapu, M., Munnangi, P., & Winner, J. (2024) · Frontiers in Health Informatics
The role of functional variants in the aetiology of polycystic ovary syndrome
Smith, R. G. (2017) · Murdoch University Research Portal
Carmina, E. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_12
Self-citationdas Neves, F. M. M. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Kirk, R. (2014) · Repository@Hull (Worktribe) (University of Hull)
Graff, S. K. (2013) · Lume (Universidade Federal do Rio Grande do Sul)
Farhadi-Azar, M., Behboudi-Gandevani, S., Rahmati, M., Mahboobifard, F., Pouya, E. K., Tehrani, F. R., & Azizi, F. (2022) · doi:10.3389/fendo.2022.825528.s001
Newell-Fugate, A. E. (2012) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Pérez, M. C. (2006) · DIGITAL.CSIC (Spanish National Research Council (CSIC))
Hormonal and Ultrasonographic Characteristics of Polycystic Ovarian Syndrome
Uddin, J. (2026) · The Planet · doi:10.5281/zenodo.20586260
Interventions in patients at high cardiovascular risk
Seña, S. G. (2011) · Repository@Hull (Worktribe) (University of Hull)
Cunha, K. D. D. (2012) · Lume (Universidade Federal do Rio Grande do Sul)
YILMAZ, S. (2017) · DSpace - FIRAT (Fırat University)
Metadata
- Authors
- Carmina, E., Chu, M. C., Longo, R. A., Rini, G. B., & Lobo, R. A.
- Affiliations
- University of Palermo (IT)
- Columbia University (US)
- Department of Obstetrics and Gynecology (M.C.C., R.A.Lob.), Columbia University, New York, New York 10032-3784
- ORCID
- Carmina, E.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-05-01
- Volume
- 90
- Issue
- 5
- Pages
- 2545-2549
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2030643176
- Cited by
- 274
- References
- 21
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 1 · 2023: 10 · 2022: 10 · 2021: 9 · 2020: 2 · 2019: 8 · 2018: 6 · 2017: 10 · 2016: 16 · 2015: 11 · 2014: 15 · 2013: 15 · 2012: 16
- FWCI
- 27.36
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, hyperandrogenism, insulin resistance, obesity, dyslipidemia, cardiovascular risk factors, C-reactive protein, homocysteine, QUICKI, metabolic risk, phenotypic classification, androgen levels, gonadotropins, body mass index
- MeSH terms
- C-Reactive Protein, Cardiovascular Diseases, Female, Humans, Insulin, Insulin Resistance, Luteinizing Hormone, Cholesterol, LDL, Phenotype, Polycystic Ovary Syndrome, Risk Factors, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.